Identification of Functional Single Nucleotide Polymorphisms in Porcine HSD17B14 Gene Associated with Estrus Behavior Difference between Large White and Mi Gilts

Steroid hormone levels are associated with estrous behavior, which affects timely mating and reproductive efficiency in pigs. 17β-hydroxysteroid dehydrogenase type 14 (HSD17B14) modulates steroid synthesis and metabolism. To identify the functional single nucleotide polymorphisms (SNPs) in the porcine HSD17B14 gene, ear tissues from Large White and Mi gilts were collected to extract genomic DNA. Variable lengths of truncated promoter of HSD17B14 gene were used to determine the promoter activity by a dual luciferase reporter system. The vector HSD17B14Phe or HSD17B14Val was transfected into porcine granulosa cells (GCs). The core promoter region was identified between −72 bp and −218 bp. Six of seven SNPs had significant differences of allele frequency between Large White and Mi gilts. The plasmids with the wild genotype AA of rs329427898 maintained a smaller fraction of promoter activity compared with the plasmids with the mutant genotype GG, while the plasmids with wild the genotype TT of rs319864566 had a greater promoter activity than the plasmids with the mutant genotype CC. A missense mutation (Phe73Val) caused changes in the structural dynamics and function of the HSD17B14 protein. The highly expressed HSD17B14Val degraded less estradiol into estrone, while the relatively lowly expressed HSD17B14Phe degraded more estradiol into estrone, suggesting the protein activity of HSD17B14Phe was greater than that of HSD17B14Val. Moreover, the HSD17B14Phe group has a greater apoptosis rate of porcine GCs. The HSD17B14 gene could been used as a candidate molecular marker for estrus behavior in pigs.

Influence of male on estrus behavior, estradiol and progesterone release and puberty onset on prepubertal Saanen goats

The present study investigated the male effect on the estrus behaviors, estradiol and progesterone release in prepubertal Saanen goats. Twenty-nine female Saanen goats at 135 ± 10 days old with body weight of 22.8 ± 3.3 Kg were randomly assigned to three treatments: exposure to sexually active male (male treatment), exposure to androgenized females (androgenized female treatment), and prepubertal goats isolated from active male and androgenized females (control treatment). Sexual behaviors associated with estrus were recorded daily, and blood samples were taken weekly to determine estradiol and progesterone concentrations over 24 weeks. The experimental goats subjected to male or androgenized female had significantly higher frequency of estrus (mount acceptance) (P ? 0,02), progesterone (P ? 0,01), and estradiol (P ? 0,01) release than the control goats. Furthermore, goats exposed to a male showed estrus behavior two weeks earlier and maintained this estrus behavior for three weeks more than goats of both female and control treatments. Estrus was observed in 70 % of goats in male and female treatments during the breeding season versus 44 % of the control goats. Finally, significantly more goats subjected to male treatment (60 % of goats) showed progesterone concentrations higher than 1 ng mL-1 (which indicates the presence of a functional corpus luteum) compared to the female and control treatment (40 and 22 % of goats, respectively). These results shows that male treatment significantly increased the number of females showing estrus behavior, estradiol and progesterone release, and the number of animals with a functional corpus luteum, anticipating puberty for experimental goats, suggesting that the male effect could be used to anticipate the onset of puberty in goats.

Efficiency of CIDR-Based Protocols Including GnRH Instead of eCG for Estrus Synchronization in Sheep

The present study examined, for meat sheep (Segureña breed; 2–5-years old, mean body score of 3.5 ± 0.5), the timings of onset of estrus behavior, preovulatory luteinizing hormone (LH) surge and ovulation, and the ovulation rate and fertility obtained after insertion of controlled internal drug release (CIDR) devices for 5 days plus treatment with equine chorionic gonadotrophin (eCG; single dose at CIDR removal, n = 19 ewes) or gonadotrophin-releasing hormone (GnRH, either in a single dose at 56 h after CIDR removal, group CIDR-GnRH, n = 19 ewes; or in one dose at CIDR insertion and another dose 56 h after CIDR removal, group GnRH-CIDR-GnRH, n = 19 ewes). In all the ewes, the appearance of estrus behavior ranged between 84% and 90% and all females showing estrus signs had subsequent preovulatory LH peaks and ovulations. Onset of these events was earlier in the CIDR-eCG group than in the CIDR-GnRH and GnRH-CIDR-GnRH groups (p < 0.05). These differences were mainly determined by the onset of estrus behavior, since timing and intervals of LH peak and ovulation were similar among treatments. In fact, the range of ovulations was narrower in the GnRH-CIDR-GnRH group, which suggests better synchronization of follicular growth (p < 0.05). In conclusion, protocols with two doses of GnRH offer similar yields to eCG protocols.